Healthcare Stocks

Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

 Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

Pharma and biotech-focused companies have seen huge investments after the onset of the pandemic. The UK received record levels of investment into its life sciences sector in 2021, with VC (Venture Capital) and PE (Private Equity) investment into th...

Read More...
An Insight on 5 Small-Cap Healthcare Stocks: Synairgen, Novacyt, Okyo, Avacta & Byotrol

An Insight on 5 Small-Cap Healthcare Stocks: Synairgen, Novacyt, Okyo, Avacta & Byotrol

Summary The unprecedented pandemic has once again diverted the spotlight on the healthcare sector Companies are escalating the production of diagnostic tests and therapeutics in the race to successfully recognise and treat patients of Covid-19 ...

Read More...
Pharmaceutical Major Merck To Invest £1 Billion In Building A R&D Centre In the UK

Pharmaceutical Major Merck To Invest £1 Billion In Building A R&D Centre In the UK

Summary Merck plans to invest £1 billion to build a new research hub in London. While the new R&D centre with a capacity of 800 people would create around 120 new jobs, MSD would bring most of its employees from other existing labs an...

Read More...
The British Biotech Sector Amidst the Coronavirus Pandemic

The British Biotech Sector Amidst the Coronavirus Pandemic

Summary The coronavirus pandemic came as a boon for several companies working in the biotech industry, as new work emerged for the development of vaccine and other therapeutics for the treatment of the ailment. Governments across the world have...

Read More...
The UK Healthcare Sector and Some Companies with Sound Performance

The UK Healthcare Sector and Some Companies with Sound Performance

Summary The healthcare sector has performed relatively well in the past few months on account of increased demand Some of the British pharmaceutical companies are on the forefront of the vaccine research being carried out against the coronaviru...

Read More...
Two AIM Listed Healthcare Stocks Trending on LSE: Genedrive PLC & Midatech Pharma PLC

Two AIM Listed Healthcare Stocks Trending on LSE: Genedrive PLC & Midatech Pharma PLC

Summary As per the industry experts in the UK, 16 percent of British employers offered no increase in wages for the three months ended in June. However, the proportion was 15 percent up from three months ended May. The UK government announced a...

Read More...
Quick Insights on Two FTSE Listed Stocks: Kromek Group & Cyanconnode Holdings

Quick Insights on Two FTSE Listed Stocks: Kromek Group & Cyanconnode Holdings

Summary As per the Eurostat report, the annual inflation in the Euro area increased to 0.3 percent in June 2020. The inflation was 0.1 percent in May 2020. Office for National Statistics reported that the gross debt of the UK government was &po...

Read More...
Performance Review of Two FTSE Listed Healthcare Stocks: Genus PLC & Indivior PLC

Performance Review of Two FTSE Listed Healthcare Stocks: Genus PLC & Indivior PLC

Summary As per the Office for Budget Responsibility report, the British economy could slump by around 14 percent in 2020. The London stocks retreated with apprehensions over the second wave of coronavirus. The FTSE-100 was down by 0.29 percent...

Read More...
The UK Government Goes in For A Second Contract to Acquire Vaccines for Its Citizens

The UK Government Goes in For A Second Contract to Acquire Vaccines for Its Citizens

Summary The UK government is close to reach a £500 million deal with Sanofi and GSK for acquiring millions of doses of COVID- 19 vaccine The Government’s decision to go in for a second vaccine contract seems to be a strategy to dive...

Read More...
COVID-19 Vaccine Development: Where Do We Stand?

COVID-19 Vaccine Development: Where Do We Stand?

COVID-19 pandemic has affected more than 10.2 million lives including 506,864 deaths reported to the World Health Organization on 01 July 2020, (as of 8:18 AM CEST). As per the information provided by the WHO, a total of 149 vaccines are being tes...

Read More...
Healthcare Sector Defying the Norms: COVID-19 Vaccines Under Development and Related Stocks

Healthcare Sector Defying the Norms: COVID-19 Vaccines Under Development and Related Stocks

COVID-19 threat still looms with countries struggling to eliminate the novel coronavirus, SARS-CoV-2. While most geographies are grappling with the first wave of virus, the ones who did become COVID-19-free are now facing the second wave. Globally,...

Read More...